Number of pages: 100 | Report Format: PDF | Published date: 05 August, 2022
Historical Years – 2020 | Base Year – 2021 | Forecasted Years – 2022-2030
The global breast cancer screening market was pegged at US$ 2.50 billion in 2021 and is expected to witness a CAGR of 6.7% during the forecast period from 2022 to 2030.
Breast cancer is a medical condition where breast cells grow rapidly and mutate, forming tumors. It can grow and invade the surrounding tissues of the breast. On metastasis, cancer can also spread to other parts of the body and can develop into other cancers. To prevent this condition, medical professionals suggest early diagnosis that can be attained by various screening methods.
The breast cancer screening market is experiencing steady growth. The rising prevalence of breast cancer in women around the globe has played a key role in expanding this market. Favorable reimbursement policies, growing awareness for regular breast checkups, and increasing government and private initiatives are all responsible for the growth of the breast cancer screening market. Additionally, technological advancements and innovations for better services and improving efficacy accelerate the overall market growth. However, there are some drawbacks to the growth of the market. These issues are the high cost of diagnostics devices and the adverse effects of screening.
The global breast cancer screening market has been analyzed from four perspectives: By Types, Product, End User, and Region.
Breast Cancer Screening Market by Type
Based on type, the global breast cancer screening market has been segmented into mammography, MRI (Magnetic Resonance Imaging), ultrasound, tomography, genome test, and biopsy. The mammography segment holds the largest share in the market and is expected to retain its dominance during the forecast period. The standard technique used for the detection of breast cancer is the imaging technique as it provides accurate results. Mammography is a primary and widely used method for the detection of tumor cells. In addition, various government bodies and private healthcare organizations have taken initiatives to provide access to mammography diagnostics for women across the globe. Thus, raising the demand for mammograms in society, thereby upsurging the global market for breast cancer screening market.
Breast Cancer Screening Market by Product
Based on the product, the global breast cancer screening market has been segmented into instrument-based products and platform-based products. Instrument-based product segment holds the largest share in the breast screening market and is further bifurcated into biopsy and imaging. Imaging diagnostic is a standard method and is a commonly preferred technique for detecting breast cancer. A biopsy is performed after the confirmation through the imaging system. Additionally, the government initiatives of spreading awareness regarding breast cancer and the utilization of advanced technologies for early detection of cancer are expected to further fuel the market growth. Moreover, the platform-based product is an emerging segment and is further segmented into PCR (Polymerase Chain Reaction), next-generation sequencing, microarrays, and others.
Breast Cancer Screening Market by End User
Based on end user, the market has been segmented into hospitals, diagnostic centers, and cancer institutes. The diagnostic centers dominate the market with the largest revenue share and are expected to show continuous dominance during the forecast period. The growth of this segment is attributed to factors such as easy accessibility and higher effectiveness. Furthermore, this segment has a large patient footfall which in turn supports the growth of this segment. Emerging advanced imaging methods such as PET (Positron Emission Tomography), CT-scan (Computed Tomography), tomography, MBI (Molecular Breast Imaging), etc., are also used in the diagnostic procedure for cancer, thereby contributing to the segment growth globally.
Breast Cancer Screening Market by Region
Based on regions, the breast cancer screening market has been segmented into North America, Europe, Asia Pacific, and Rest of the World. North America dominates the global market with the largest market share. The leading position of the region can be attributed to the rising prevalence of breast cancer, large patient base, increasing government/private initiatives, strategic expansion of diagnostic & screening companies, the adoption of technological advancements, and many more. Additionally, enhanced healthcare infrastructure and favorable reimbursement policies are expected to further promote the growth of the market.
Some of the prominent players operating in the global breast cancer screening market are: